메뉴 건너뛰기




Volumn 72, Issue 7, 2012, Pages 789-802

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer

Author keywords

aCGH; androgen receptor signaling; gene expression; gene silencing; prostate cancer cell growth

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ATP1B1 PROTEIN; BICALUTAMIDE; BUSERELIN; CYPROTERONE ACETATE; DNA; DUTASTERIDE; ETHINYLESTRADIOL; FAM110B PROTEIN; FLUTAMIDE; GOSERELIN; LAS1L PROTEIN; MYC PROTEIN; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; YIPF6 PROTEIN;

EID: 84860338524     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21487     Document Type: Article
Times cited : (24)

References (33)
  • 1
    • 1842612442 scopus 로고    scopus 로고
    • Androgen receptor outwits prostate cancer drugs
    • DOI 10.1038/nm0104-26
    • Isaacs JT, Isaacs WB,. Androgen receptor outwits prostate cancer drugs. Nat Med 2004; 10 (1): 26-27. (Pubitemid 38524693)
    • (2004) Nature Medicine , vol.10 , Issue.1 , pp. 26-27
    • Isaacs, J.T.1    Isaacs, W.B.2
  • 3
    • 0035496220 scopus 로고    scopus 로고
    • The development of androgen-independent prostate cancer
    • Feldman BJ, Feldman D,. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1 (1): 34-45. (Pubitemid 33741879)
    • (2001) Nature Reviews Cancer , vol.1 , Issue.1 , pp. 34-45
    • Feldman, B.J.1    Feldman, D.2
  • 4
    • 4744347762 scopus 로고    scopus 로고
    • Mechanisms of androgen-refractory prostate cancer
    • DOI 10.1056/NEJMp048178
    • Debes JD, Tindall DJ,. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 2004; 351 (15): 1488-1490. (Pubitemid 39315314)
    • (2004) New England Journal of Medicine , vol.351 , Issue.15 , pp. 1488-1490
    • Debes, J.D.1    Tindall, D.J.2
  • 5
    • 0029077281 scopus 로고
    • Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
    • Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R,. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995; 55 (19): 4438-4445.
    • (1995) Cancer Res , vol.55 , Issue.19 , pp. 4438-4445
    • Raffo, A.J.1    Perlman, H.2    Chen, M.W.3    Day, M.L.4    Streitman, J.S.5    Buttyan, R.6
  • 7
    • 33645690200 scopus 로고    scopus 로고
    • Mechanisms underlying the development of androgen-independent prostate cancer
    • Pienta KJ, Bradley D,. Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 2006; 12 (6): 1665-1671.
    • (2006) Clin Cancer Res , vol.12 , Issue.6 , pp. 1665-1671
    • Pienta, K.J.1    Bradley, D.2
  • 9
    • 54849435425 scopus 로고    scopus 로고
    • Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol
    • Dillard PR, Lin MF, Khan SA,. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Mol Cell Endocrinol 2008; 295 (1-2): 115-120.
    • (2008) Mol Cell Endocrinol , vol.295 , Issue.12 , pp. 115-120
    • Dillard, P.R.1    Lin, M.F.2    Khan, S.A.3
  • 10
    • 70350244512 scopus 로고    scopus 로고
    • Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens
    • Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T,. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res 2009; 69 (20): 8141-8149.
    • (2009) Cancer Res , vol.69 , Issue.20 , pp. 8141-8149
    • Waltering, K.K.1    Helenius, M.A.2    Sahu, B.3    Manni, V.4    Linja, M.J.5    Jänne, O.A.6    Visakorpi, T.7
  • 11
    • 67449119425 scopus 로고    scopus 로고
    • Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven
    • Attard G, Reid AH, Olmos D, de Bono JS,. Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven. Cancer Res 2009; 69 (12): 4937-4940.
    • (2009) Cancer Res , vol.69 , Issue.12 , pp. 4937-4940
    • Attard, G.1    Reid, A.H.2    Olmos, D.3    De Bono, J.S.4
  • 12
    • 34250221096 scopus 로고    scopus 로고
    • Characterization of the FAM110 gene family
    • DOI 10.1016/j.ygeno.2007.03.002, PII S0888754307000596
    • Hauge H, Patzke S, Aasheim HC,. Characterization of the FAM110 gene family. Genomics 2007; 90 (1): 14-27. (Pubitemid 46900995)
    • (2007) Genomics , vol.90 , Issue.1 , pp. 14-27
    • Hauge, H.1    Patzke, S.2    Aasheim, H.-C.3
  • 13
    • 70349766695 scopus 로고    scopus 로고
    • Evidence for the involvement of FAM110C protein in cell spreading and migration
    • Hauge H, Fjelland KE, Sioud M, Aasheim HC,. Evidence for the involvement of FAM110C protein in cell spreading and migration. Cell Signal 2009; 21 (12): 1866-1873.
    • (2009) Cell Signal , vol.21 , Issue.12 , pp. 1866-1873
    • Hauge, H.1    Fjelland, K.E.2    Sioud, M.3    Aasheim, H.C.4
  • 14
    • 0019023345 scopus 로고
    • Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA
    • Auffray C, Rougeon F,. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1980; 107 (2): 303-314.
    • (1980) Eur J Biochem , vol.107 , Issue.2 , pp. 303-314
    • Auffray, C.1    Rougeon, F.2
  • 18
    • 4544341015 scopus 로고    scopus 로고
    • Linear models and empirical bayes methods for assessing differential expression in microarray experiments
    • Article 3
    • Smyth GK,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article 3.
    • (2004) Stat Appl Genet Mol Biol , vol.3
    • Smyth, G.K.1
  • 21
    • 0033551378 scopus 로고    scopus 로고
    • The role of c-myc in cellular growth control
    • DOI 10.1038/sj.onc.1202751
    • Schmidt EV,. The role of c-myc in cellular growth control. Oncogene 1999; 18 (19): 2988-2996. (Pubitemid 29276538)
    • (1999) Oncogene , vol.18 , Issue.19 , pp. 2988-2996
    • Schmidt, E.V.1
  • 22
    • 72949116221 scopus 로고    scopus 로고
    • From pathogenesis to prevention of castration resistant prostate cancer
    • Bonkhoff H, Berges R,. From pathogenesis to prevention of castration resistant prostate cancer. Prostate 2010; 70 (1): 100-112.
    • (2010) Prostate , vol.70 , Issue.1 , pp. 100-112
    • Bonkhoff, H.1    Berges, R.2
  • 25
    • 57149087679 scopus 로고    scopus 로고
    • Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer
    • Wang G, Wang J, Sadar MD,. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer. Cancer Res 2008; 68 (23): 9918-9927.
    • (2008) Cancer Res , vol.68 , Issue.23 , pp. 9918-9927
    • Wang, G.1    Wang, J.2    Sadar, M.D.3
  • 28
    • 0035320526 scopus 로고    scopus 로고
    • A fresh look at tumor immunosurveillance and immunotherapy
    • DOI 10.1038/86297
    • Smyth MJ, Godfrey DI, Trapani JA,. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001; 2 (4): 293-299. (Pubitemid 33706339)
    • (2001) Nature Immunology , vol.2 , Issue.4 , pp. 293-299
    • Smyth, M.J.1    Godfrey, D.I.2    Trapani, J.A.3
  • 29
    • 0028818052 scopus 로고
    • Loss of HLA class i expression in prostate cancer: Implications for immunotherapy
    • Blades RA, Keating PJ, McWilliam LJ, George NJ, Stern PL,. Loss of HLA class I expression in prostate cancer: Implications for immunotherapy. Urology 1995; 46 (5): 681-687.
    • (1995) Urology , vol.46 , Issue.5 , pp. 681-687
    • Blades, R.A.1    Keating, P.J.2    McWilliam, L.J.3    George, N.J.4    Stern, P.L.5
  • 30
    • 0030834459 scopus 로고    scopus 로고
    • MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma
    • DOI 10.1002/(SICI)1097-0045(19971201)33:4<233::AID-PROS2>3.0.CO;2-I
    • Bander NH, Yao D, Liu H, Chen YT, Steiner M, Zuccaro W, Moy P,. MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma. Prostate 1997; 33 (4): 233-239. (Pubitemid 27524701)
    • (1997) Prostate , vol.33 , Issue.4 , pp. 233-239
    • Bander, N.H.1    Yao, D.2    Liu, H.3    Chen, Y.-T.4    Steiner, M.5    Zuccaro, W.6    Moy, P.7
  • 31
    • 0034109776 scopus 로고    scopus 로고
    • Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells
    • Lee HM, Timme TL, Thompson TC,. Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells. Cancer Res 2000; 60 (7): 1927-1933. (Pubitemid 30207654)
    • (2000) Cancer Research , vol.60 , Issue.7 , pp. 1927-1933
    • Lee, H.-M.1    Timme, T.L.2    Thompson, T.C.3
  • 32
    • 3042701410 scopus 로고    scopus 로고
    • Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class i expression in high-grade prostate cancer
    • Zhang H, Melamed J, Wei P, Cox K, Frankel W, Bahnson RR, Robinson N, Pyka R, Liu Y, Zheng P,. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer. Cancer Immun 2003; 3: 2.
    • (2003) Cancer Immun , vol.3 , pp. 2
    • Zhang, H.1    Melamed, J.2    Wei, P.3    Cox, K.4    Frankel, W.5    Bahnson, R.R.6    Robinson, N.7    Pyka, R.8    Liu, Y.9    Zheng, P.10
  • 33
    • 0034622416 scopus 로고    scopus 로고
    • Changes in beta-2 microglobulin expression in prostate cancer
    • DOI 10.1016/S1078-1439(00)00063-6, PII S1078143900000636
    • Abdul M, Hoosein N,. Changes in beta-2 microglobulin expression in prostate cancer. Urol Oncol 2000; 5 (4): 168-172. (Pubitemid 30408540)
    • (2000) Urologic Oncology , vol.5 , Issue.4 , pp. 168-172
    • Abdul, M.1    Hoosein, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.